These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 14741697)
1. Replacement of 198MQMDII203 of mouse IRF-1 by 197IPVEVV202 of human IRF-1 abrogates induction of IFN-beta, iNOS, and COX-2 gene expression by IRF-1. Upreti M; Kumar S; Rath PC Biochem Biophys Res Commun; 2004 Feb; 314(3):737-44. PubMed ID: 14741697 [TBL] [Abstract][Full Text] [Related]
3. Interplay between repressing and activating domains defines the transcriptional activity of IRF-1. Kirchhoff S; Oumard A; Nourbakhsh M; Levi BZ; Hauser H Eur J Biochem; 2000 Dec; 267(23):6753-61. PubMed ID: 11082185 [TBL] [Abstract][Full Text] [Related]
4. Regulation of type I interferon gene expression by interferon regulatory factor-3. Schafer SL; Lin R; Moore PA; Hiscott J; Pitha PM J Biol Chem; 1998 Jan; 273(5):2714-20. PubMed ID: 9446577 [TBL] [Abstract][Full Text] [Related]
5. KE-298 and its active metabolite KE-758 suppress nitric oxide production by murine macrophage cells and peritoneal cells from rats with adjuvant induced arthritis. Inoue T; Hamada Y; Takeshita K; Fukushima K; Higaki M J Rheumatol; 2001 Jun; 28(6):1229-37. PubMed ID: 11409114 [TBL] [Abstract][Full Text] [Related]
6. The role of the interferon regulatory factors, IRF-1 and IRF-2, in LPS-induced cyclooxygenase-2 (COX-2) expression in vivo and in vitro. Zhang S; Thomas K; Blanco JC; Salkowski CA; Vogel SN J Endotoxin Res; 2002; 8(5):379-88. PubMed ID: 12537697 [TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of interferon (IFN) regulatory factors 1 and 2. Effects on the induction of IFN-beta gene expression. Lin R; Mustafa A; Nguyen H; Gewert D; Hiscott J J Biol Chem; 1994 Jul; 269(26):17542-9. PubMed ID: 8021262 [TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 downregulates inducible nitric oxide synthase in rat intestinal epithelial cells. Kobayashi O; Miwa H; Watanabe S; Tsujii M; Dubois RN; Sato N Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G688-96. PubMed ID: 11518681 [TBL] [Abstract][Full Text] [Related]
14. Replacement of the C-terminal tetrapeptide (314 PAPV 317 to 314 SSSM 317) in interferon regulatory factor-2 alters its N-terminal DNA-binding activity. Prakash K; Rath PC J Biosci; 2010 Dec; 35(4):547-56. PubMed ID: 21289437 [TBL] [Abstract][Full Text] [Related]
15. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain. Nguyen H; Mustafa A; Hiscott J; Lin R Oncogene; 1995 Aug; 11(3):537-44. PubMed ID: 7630638 [TBL] [Abstract][Full Text] [Related]
16. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Au WC; Moore PA; Lowther W; Juang YT; Pitha PM Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11657-61. PubMed ID: 8524823 [TBL] [Abstract][Full Text] [Related]
17. Effect of cycloheximide on the expression of LPS-inducible iNOS, IFN-beta, and IRF-1 genes in J774 macrophages. Hattori Y; Akimoto K; Matsumura M; Tseng CC; Kasai K; Shimoda S Biochem Mol Biol Int; 1996 Nov; 40(5):889-96. PubMed ID: 8955877 [TBL] [Abstract][Full Text] [Related]